AEGiS-APPJ: How AIDS Became a Race Issue: The Case of Alabama AIDS & Public Policy JournalImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow
Print this Article


How AIDS Became a Race Issue: The Case of Alabama

AIDS & Public Policy Journal 17, no. 2 (Summer 2002) 59-74
Bronwen Lichtenstein


HIV/AIDS in the United States was originally conceptualized as a "White man's disease." This perception initially shaped responses to HIV/AIDS on a national and regional basis. It is now recognized that minorities are disproportionately at risk of HIV/AIDS, but policy makers have been slow to address this issue, and problems remain in formulating HIV-prevention strategies for minority populations. The present article examines how AIDS became a "race issue" in Alabama by analyzing state policies and programs over a 20-year period (1982-2002). It was found that African-Americans experienced greater rates of HIV transmission from the outset, and that infection rates among Blacks have increased since 1990, while those for Whites have declined. These facts have been obscured by the "White man" stereotype that shaped early responses to HIV/AIDS, by the state's focus on gathering surveillance statistics rather than on targeted prevention, and by bifurcated racial politics that tacitly supported the notion of a "White" epidemic. The present analysis concludes that Alabama relied on national guidelines and funding that did not specifically address the racial dimensions of the epidemic until the 1990s, and that targeted programs for African-Americans are still deficient despite some recent initiatives.
020615
APPJ021702-02

Copyright © 2002 - AIDS & Public PolicyJournal. Reproduction of this article (other than one copy for personal reference) must be cleared through the APPJ Permissions Desk.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1986, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .